Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: An exploration study

Blood

Volumn 119, Issue 26, 2012, Pages 6365-6372

  Harkensee, Christian ^a,b   Oka, Akira ^a   Onizuka, Makoto ^a   Middleton, Peter G ^b   Inoko, Hidetoshi ^a   Hirayasu, Kouyuki ^c,d   Kashiwase, Koichi ^d   Yabe, Toshio ^d   Nakaoka, Hirofumi ^a,e   Gennery, Andrew R ^b   Ando, Kiyoshi ^a   Morishima, Yasuo ^f  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c OSAKA UNIVERSITY   (Japan)

^d Japanese Red Cross Tokyo Blood Center   (Japan)

^e NATIONAL INSTITUTE OF GENETICS   (Japan)

^f AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84863510697     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-406785     Document Type: Article

References (39)

1. Hansen JA, Petersdorf EW, Lin MT, et al. Genetics of allogeneic hematopoietic cell transplantation: role of HLA matching, functional variation in immune response genes. Immunol Res. 2008;41(1):56-78.
2. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev. 2002;190:40-52. (Pubitemid 36071925)
3. Yabe T, Matsuo K, Hirayasu K, et al. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation. Biol Blood Marrow Transplant. 2008;14(1):75-87. (Pubitemid 350286743)
4. Kawase T, Nanya Y, Torikai H, et al. Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA. Blood. 2008;110(6):3286-3294.
5. Ogawa S, Matsubara A, Onizuka M, et al. Exploration of the genetic basis of GVHD by genetic association studies. Biol Blood Marrow Transplant. 2008;15(1 Suppl):39-41.
6. Hansen JA, Chien JW, Warren EH, Zhao LP, Martin PJ. Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation. Curr Opin Hematol. 2010;17(6):483-492.
7. Choi SW, Levine JE, Ferrara JL. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin North Am. 2010;30(1):75-101.
8. Billingham RE. The biology of graft-versus-host reactions. Harvey Lect. 1966;62:21-78.
9. Martín-Antonio B, Granell M, Urbano-Ispizua Á. Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation. Expert Rev Hematol. 2010;3(4):411-427.
10. Weissinger EM, Dickinson AM. Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications. Cancer Treat Res. 2009;144:95-129.
11. Ferrara JL, Krenger W. Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines. Transfus Med Rev. 1998;12(1):1-17. (Pubitemid 28048139)
12. Socié G. Graft-versus-host disease: proteomics comes of age. Blood. 2009;113(2):271-272.
13. Teshima T, Ordemann R, Reddy P, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8(6):575-581. (Pubitemid 34633434)
14. Buzzeo MP, Yang J, Casella G, Reddy V. A preliminary gene expression profile of acute graft-versus-host disease. Cell Transplant. 2008;17(5):489-494.
15. Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus-host disease. Blood. 2009;113(2):273-278.
16. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98(7):2043-2051.
17. Loren AW, Bunin GR, Boudreau C, et al. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12(7):758-769. (Pubitemid 43899412)
18. Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood. 2004;103(1):347-352. (Pubitemid 38029959)
19. Pérez-Simón JA, Diez-Campelo M, Martino R, et al. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation. Br J Haematol. 2005;130(3):394-403. (Pubitemid 43899588)
20. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 2003;361(9360):865-872. (Pubitemid 36331853)
21. Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet. 2000;355(9200):308-311. (Pubitemid 30068531)
22. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4(2):45-61. (Pubitemid 44698579)
23. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265(5181):2037-2048. (Pubitemid 24325685)
24. Schork NJ. Genetics of complex disease: approaches, problems, and solutions. Am J Respir Crit Care Med. 1997;156(4):S103-S109. (Pubitemid 27449321)
25. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor: Japan Marrow Donor Program. N Engl J Med. 1998;339(17):1177-1185. (Pubitemid 28482126)
26. Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002;99(11):4200-4206. (Pubitemid 35332066)
27. Weisdorf D, Spellman S, Haagenson M, et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant. 2008;14(7):748-758. (Pubitemid 351773151)
28. Morishima Y, Yabe T, Matsuo K, et al. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol Blood Marrow Transplant. 2007;13(3):315-328.
29. Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele mismatch combinations responsible for severe acute graft versus host disease and implication for its molecular mechanism. Blood. 2007;110(7):2235-2241. (Pubitemid 47523140)
30. Kawase T, Matsuo K, Kashiwase K, et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood. 2009;113(12):2851-2858.
31. Morishima S, Ogawa S, Matsubara A, et al. Impact of highly conserved HLA haplotype on acute graft-versus-host disease. Blood. 2010;115(23):4664-4670.
32. MacMillan ML, Radloff GA, Kiffmeyer WR, DeFor TE, Weisdorf DJ, Davies SM. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation. Transplantation. 2003;76(12):1758-1762. (Pubitemid 38032426)
33. Ishikawa Y, Kashiwase K, Akaza T, et al. Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplant. 2002;29(7):569-575. (Pubitemid 34537716)
34. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998;51(6):605-612. (Pubitemid 28306464)
35. Goyal RK, Lin Y, Schultz KR, et al. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study. Biol Blood Marrow Transplant. 2010;16(7):927-936.
36. Das H, Imoto S, Murayama T, et al. Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion. Bone Marrow Transplant. 2001;27(4):373-380. (Pubitemid 32201345)
37. Pérez-Garcia A, De la Camara R, Roman-Gomez J, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood. 2007;110(1):461-467. (Pubitemid 47026869)
38. Murase M, Nishida T, Onizuka M, et al. Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2011;46(11):1444-1449.
39. Vannucchi AM, Guidi S, Guglielmelli P, et al. Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;40(10):1001-1002. (Pubitemid 350048202)